54 072 54 072 (Hydroxyurea 500 mg)
Pill imprint 54 072 54 072 has been identified as Hydroxyurea 500 mg.
Hydroxyurea is used in the treatment of thrombocythemia; anemia, sickle cell; polycythemia vera; chronic myelogenous leukemia; solid tumors (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about hydroxyurea
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.